Sahar Fathallah Shaykh, MD
Pediatric Nephrology · Birmingham, ALNPI 1033187505
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,500 of the $4,577 with a category attached, or 98.3%. Bayer accounts for 98.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $4,535 and has fallen 99.5% since, to $24 in 2025.
Across 6 payments — averaging $762.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$4K
- Apellis Pharmaceuticals, Inc.$24
- Recordati_rare_diseases_inc.$21
- Baxter Healthcare$18
- CMP Pharma, Inc.$14
Across 45 payments — averaging $10,138 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$135K
- Genentech, Inc.$88K
- Akebia Therapeutics Inc$66K
- Cormedix Inc.$52K
- Vifor Fresenius Medical Care Renal Pharma Ltd.$40K
- Bayer$33K
- plus $42K from 2 others
What the payments were for
- Consulting fees$4,50098%
- Food & beverage$772%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 2 | $4,500 |
| Apellis Pharmaceuticals, Inc. | 1 | $24 |
| Recordati_rare_diseases_inc. | 1 | $21 |
| Baxter Healthcare | 1 | $18 |
| CMP Pharma, Inc. | 1 | $14 |
How this compares
Too few pediatric nephrology providers in Alabamato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 13 | $1,338 |
| Lisinopril | 12 | $16 |
| Amlodipine Besylate | 11 | $10 |
Paid to pharmacies, not to this prescriber.
Other pediatric nephrology in Birmingham
- David AskenaziBirmingham$114K
- Daniel FeigBirmingham$11K
- Tennille WebbBirmingham$519
- Caroline JacksonBirmingham$308
- Kyle DevilleBirmingham$296
- Michael SeifertBirmingham$221
- Andrew BarberaBirmingham$119
- Rebekah SimsBirmingham$113
- Gabrielle LeonardBirmingham$78
- Mark BenfieldCullman$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.